At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gene Modulation of NLRP3, IL-1β and TNF-α in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine
In Brief
A clinical study evaluating Berberine Hydrochloride group, nutritional plan, and 1 other intervention for Obesity and 2 related conditions. Completed, enrolled 120 participants.
Detailed Summary
The patients will be invited to participate in a research study aimed at determining the Gene Modulation of NLRP3, IL-1β and TNFα in peripheral blood of patients with exogenous obesity treated with berberine.
Study Details
Timeline
Interventions
The patient will be given a nutritional plan, moderate aerobic exercise with a goal of 10,000 steps or 150 min per week; and the phytopharmaceutical Berberine will be taken 3 tablets ( 500 mg) every 8 hours for 3 months.
nutritional plan according to your caloric requirements for lifestyle change and you will be scheduled biweekly for 3 months
controlled moderate aerobic exercise that will consist of a goal of 10,000 steps or 150 minutes per week.